InvestorsObserver
×
News Home

Is TC BioPharm Ltd (TCBP) a Good Buy in the Biotechnology Industry?

Friday, January 13, 2023 03:13 PM | InvestorsObserver Analysts

Mentioned in this article

Is TC BioPharm Ltd (TCBP) a Good Buy in the Biotechnology Industry?

A rating of 24 puts TC BioPharm Ltd (TCBP) near the bottom of the Biotechnology industry according to InvestorsObserver. TC BioPharm Ltd's score of 24 means it scores higher than 24% of stocks in the industry. TC BioPharm Ltd also received an overall rating of 37, putting it above 37% of all stocks. Biotechnology is ranked 20 out of the 148 industries.

Overall Score - 37
TCBP has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on TCBP!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 37 would rank higher than 37 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With TC BioPharm Ltd Stock Today?

TC BioPharm Ltd (TCBP) stock is trading at $5.01 as of 3:11 PM on Friday, Jan 13, a rise of $0.55, or 12.44% from the previous closing price of $4.46. Volume today is elevated. So far 7,145,710 shares have traded compared to average volume of 135,693 shares. The stock has traded between $4.46 and $9.61 so far today. Click Here to get the full Stock Report for TC BioPharm Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App